Laurion Capital Management LP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 64 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$3,439,327
-3.7%
1,476,106
-1.6%
0.02%
+5.0%
Q2 2023$3,570,000
+29.3%
1,500,0000.0%0.02%
+5.3%
Q1 2023$2,760,000
-3.2%
1,500,0000.0%0.02%
+46.2%
Q4 2022$2,850,000
+225.3%
1,500,000
+881.4%
0.01%
+160.0%
Q1 2021$876,000
-19.0%
152,847
+126.4%
0.01%
-58.3%
Q2 2020$1,082,000
+52.2%
67,519
-43.1%
0.01%
+50.0%
Q1 2020$711,000
-2.6%
118,734
+162.0%
0.01%
+14.3%
Q2 2019$730,0000.0%45,314
+87.3%
0.01%0.0%
Q3 2018$730,000
-63.7%
24,190
-67.7%
0.01%
-56.2%
Q2 2018$2,009,00075,0000.02%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders